Neonatal Thyrotoxicosis - 28/02/18
Résumé |
Neonatal thyrotoxicosis (hyperthyroidism) is less prevalent than congenital hypothyroidism; however, it can lead to significant morbidity and mortality if not promptly recognized and adequately treated. Most cases are transient, secondary to maternal autoimmune hyperthyroidism (Graves disease [GD]). This article summarizes recommendations for screening and management of hyperthyroidism in both the fetal and neonatal periods, with a focus on neonatal thyrotoxicosis secondary to maternal GD. Early monitoring and treatment are crucial for optimizing short-term and long-term patient outcomes.
Le texte complet de cet article est disponible en PDF.Keywords : Neonatal, Fetal, Thyrotoxicosis, Hyperthyroidism, Graves disease
Plan
| Disclosure: The authors do not have any commercial or financial conflicts of interested to report. |
|
| Funding: Research reported in this article for (S.L. Samuels) was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number TL1TR001880. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. |
Vol 45 - N° 1
P. 31-40 - mars 2018 Retour au numéro
Article précédent
- Thyroid Function in the Neonatal Intensive Care Unit
- Monika Chaudhari, Jonathan L. Slaughter
- Neonatal Diabetes Mellitus : An Update on Diagnosis and Management
- Michelle Blanco Lemelman, Lisa Letourneau, Siri Atma W. Greeley
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?